£90.00 ($1.19)

-2.50 (-2.70%)

Weekly Expected Move ±1.4%

£90 £91 £92 £94 £95

LSE · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 46 · £103.2M mcap · 62M float · 0.012% daily turnover

Analysis Technicals Weather Peers

Revenue

$198M -2.5% ▼

5Y CAGR: +26.5%

Gross Profit

$103M -0.1% ▼

5Y CAGR: +30.3%

Operating Income

$3M +18.2% ▲

5Y CAGR: -15.5%

Net Income

-$5M -362.2% ▼

EPS (Diluted)

$-0.05 -362.2% ▼

EBITDA

$16M -8.8% ▼

5Y CAGR: +12.3%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$47M	$183M	$201M	$203M	$198M
YoY Growth	-22.6%	+285.2%	+10.0%	+1.2%	-2.5%
Cost of Revenue	$27M	$131M	$126M	$100M	$95M
Gross Profit	$21M	$116M	$122M	$104M	$103M
Gross Margin	43.3%	63.4%	60.9%	50.9%	52.2%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$23M	$114M	$124M	$101M	$100M
Operating Expenses	$23M	$85M	$100M	$101M	$100M
Operating Income	-$2M	$1M	-$1M	$3M	$3M
Operating Margin	-4.5%	0.6%	-0.6%	1.4%	1.7%
Interest Expense	$631K	$2M	$3M	$4M	$4M
Income Before Tax	-$8M	-$9M	-$8M	$215K	-$1M
Tax Expense	-$2M	-$3M	-$1M	$1M	$4M
Net Income	-$7M	-$4M	-$6M	-$997K	-$5M
Net Margin	-13.8%	-2.2%	-3.1%	-0.5%	-2.3%
EPS (Diluted)	$-0.13	$-0.04	$-0.07	$-0.01	$-0.05
EBITDA	-$5M	$6M	$8M	$17M	$16M
Shares Outstanding	69M	106M	102M	102M	102M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$115M	$111M	$92M	$103M	$95M	$98M	$94M	$99M
Cost of Revenue	$69M	$61M	$52M	$55M	$52M	$53M	$51M	$51M
Gross Profit	$46M	$51M	$40M	$48M	$43M	$45M	$43M	$48M
Gross Margin	40.0%	45.4%	43.4%	46.4%	45.0%	45.6%	45.5%	48.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$54M	$46M	$42M	$45M	$43M	$42M	$40M	$42M
Operating Expenses	$54M	$46M	$42M	$45M	$56M	$42M	$40M	$42M
Operating Income	-$8M	$5M	-$2M	$3M	$97K	$3M	$3M	$6M
Operating Margin	-6.6%	4.1%	-1.8%	3.2%	0.1%	2.8%	3.1%	6.0%
Interest Expense	$2M	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Income Before Tax	-$11M	$4M	-$4M	$1M	-$2M	$2M	-$3M	$2M
Tax Expense	-$5M	$2M	-$508K	$2M	$1M	$2M	$962K	$2M
Net Income	-$5M	$2M	-$3M	-$1M	-$4M	-$5M	-$509K	-$488K
Net Margin	-4.6%	1.9%	-3.3%	-1.0%	-3.8%	-4.7%	-0.5%	-0.5%
EPS (Diluted)	$-0.05	$0.02	$-0.03	$-0.01	$-0.04	$-0.05	$-0.02	$-0.00
EBITDA	$1M	$12M	$5M	$10M	$6M	$10M	$9M	$10M
Shares Outstanding	102M	102M	102M	102M	102M	102M	101M	102M

SPEC.L LSE